A. Mosnier

576 total citations
30 papers, 323 citations indexed

About

A. Mosnier is a scholar working on Epidemiology, Infectious Diseases and Dermatology. According to data from OpenAlex, A. Mosnier has authored 30 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 7 papers in Infectious Diseases and 5 papers in Dermatology. Recurrent topics in A. Mosnier's work include Influenza Virus Research Studies (11 papers), Respiratory viral infections research (8 papers) and Pneumonia and Respiratory Infections (4 papers). A. Mosnier is often cited by papers focused on Influenza Virus Research Studies (11 papers), Respiratory viral infections research (8 papers) and Pneumonia and Respiratory Infections (4 papers). A. Mosnier collaborates with scholars based in France, Netherlands and Canada. A. Mosnier's co-authors include W J Paget, Thomas Henry, Jacobus van der Velden, Tomás Vega, Helmut Uphoff, Anders Sjöstedt, Amandine Martin, Wayne Conlan, Igor Golovliov and Helena Lindgren and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Clinical Microbiology and Journal of Investigative Dermatology.

In The Last Decade

A. Mosnier

25 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Mosnier France 11 166 83 70 47 36 30 323
Stephanie H. Stovall United States 10 246 1.5× 30 0.4× 60 0.9× 39 0.8× 18 0.5× 17 398
Micha Löbermann Germany 9 135 0.8× 153 1.8× 28 0.4× 49 1.0× 9 0.3× 44 380
Taff Jones Canada 11 260 1.6× 155 1.9× 60 0.9× 152 3.2× 16 0.4× 20 396
Hedwig Roggendorf Germany 11 227 1.4× 152 1.8× 27 0.4× 82 1.7× 13 0.4× 24 399
Cecilia Fazio Italy 16 515 3.1× 50 0.6× 61 0.9× 79 1.7× 30 0.8× 52 676
B. Delaere Belgium 9 165 1.0× 97 1.2× 28 0.4× 18 0.4× 24 0.7× 19 322
A Ohlin United States 6 216 1.3× 68 0.8× 49 0.7× 64 1.4× 12 0.3× 6 377
Tian Bai China 15 395 2.4× 225 2.7× 51 0.7× 76 1.6× 18 0.5× 35 516
Fernanda Guedes Brazil 9 77 0.5× 148 1.8× 20 0.3× 44 0.9× 14 0.4× 22 301
Abdulbaset Salim United States 7 263 1.6× 122 1.5× 35 0.5× 18 0.4× 15 0.4× 12 394

Countries citing papers authored by A. Mosnier

Since Specialization
Citations

This map shows the geographic impact of A. Mosnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mosnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mosnier more than expected).

Fields of papers citing papers by A. Mosnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Mosnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mosnier. The network helps show where A. Mosnier may publish in the future.

Co-authorship network of co-authors of A. Mosnier

This figure shows the co-authorship network connecting the top 25 collaborators of A. Mosnier. A scholar is included among the top collaborators of A. Mosnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Mosnier. A. Mosnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patra, Vijaykumar, Slave Trajanoski, Vanina Lenief, et al.. (2025). Urocanase-Positive Skin-Resident Bacteria Metabolize cis-Urocanic Acid and in Turn Reduce the Immunosuppressive Properties of UVR. Journal of Investigative Dermatology. 145(11). 2839–2853.e6. 3 indexed citations
2.
Vocanson, Marc, et al.. (2024). Simultaneous Immediate and Delayed Hypersensitivity to Galcanezumab—Case Report. Contact Dermatitis. 92(5). 395–397.
4.
Ambert‐Balay, Katia, et al.. (2022). Respiratory tract outbreak modeling with case definition criteria: A proposal for a standardized clinical approach in nursing homes. Infectious Diseases Now. 52(6). 365–370. 2 indexed citations
5.
Lenief, Vanina, A. Mosnier, Gwendoline Dubois, et al.. (2022). Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets. Journal of Allergy and Clinical Immunology. 150(5). 1194–1208. 12 indexed citations
6.
Nosbaum, Audrey, Aurore Rozières, Vanina Lenief, et al.. (2021). Unique molecular signatures typify skin inflammation induced by chemical allergens and irritants. Allergy. 76(12). 3697–3712. 21 indexed citations
7.
Berry, I., Ashleigh R. Tuite, Steven J. Drews, et al.. (2020). Influenza increases invasive meningococcal disease risk in temperate countries. Clinical Microbiology and Infection. 26(9). 1257.e1–1257.e7. 23 indexed citations
8.
Braun, C., A. Mosnier, Tiphaine Lefebvre, et al.. (2020). Detection of skin alterations in mild-to-moderate chronic venous disease using non-invasive techniques. European Journal of Dermatology. 30(5). 505–515. 1 indexed citations
9.
Wallet, Pierre, Sacha Benaoudia, A. Mosnier, et al.. (2017). IFN-γ extends the immune functions of Guanylate Binding Proteins to inflammasome-independent antibacterial activities during Francisella novicida infection. PLoS Pathogens. 13(10). e1006630–e1006630. 39 indexed citations
10.
Mosnier, A., Isabelle Daviaud, Jean‐Sébastien Casalegno, et al.. (2017). Influenza B burden during seasonal influenza epidemics in France. Médecine et Maladies Infectieuses. 47(1). 11–17. 9 indexed citations
11.
Golovliov, Igor, Helena Lindgren, Wayne Conlan, et al.. (2016). An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy. Frontiers in Cellular and Infection Microbiology. 6. 152–152. 16 indexed citations
12.
Mélanie, Rigard, Jeanette E. Bröms, A. Mosnier, et al.. (2016). Francisella tularensis IglG Belongs to a Novel Family of PAAR-Like T6SS Proteins and Harbors a Unique N-terminal Extension Required for Virulence. PLoS Pathogens. 12(9). e1005821–e1005821. 37 indexed citations
13.
Ambert‐Balay, Katia, A. Mosnier, Serge Aho, et al.. (2015). Burden of gastroenteritis outbreaks: specific epidemiology in a cohort of institutions caring for dependent people. Journal of Hospital Infection. 91(1). 19–27. 6 indexed citations
14.
Michel, Philippe, et al.. (2014). Incidence des événements indésirables associés aux soins en médecine générale : l’étude ESPRIT 2013. Revue d Épidémiologie et de Santé Publique. 62. S178–S179. 1 indexed citations
16.
Blanchon, Thierry, France Mentré, A. Mosnier, et al.. (2011). Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter. Clinical Microbiology and Infection. 19(2). 196–203. 11 indexed citations
17.
Meerhoff, T J, et al.. (2009). Progress in the surveillance of respiratory syncytial virus (RSV) in Europe: 2001-2008. Eurosurveillance. 14(40). 22 indexed citations
20.
Paget, W J, et al.. (2003). Heterogeneous case definitions used for the surveillance of influenza in Europe. European Journal of Epidemiology. 18(8). 751–754. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026